Loading...
Loading...
Analysts at Cantor Fitzgerald initiated coverage on
Ross Stores, Inc.ROST with a Hold rating. The target price for Ross Stores is set to $110. Ross Stores' shares closed at $102.29 yesterday.
Analysts at Wunderlich initiated coverage on
Jernigan Capital Inc.JCAP with a Buy rating. The target price for Jernigan Capital is set to $25. Jernigan Capital's shares closed at $21.30 yesterday.
Analysts at FBR Capital initiated coverage on
Regulus Therapeutics IncRGLS with a Outperform rating. The target price for Regulus Therapeutics is set to $30. Regulus Therapeutics' shares closed at $17.18 yesterday.
Stifel Nicolaus initiated coverage on
Summit Materials IncSUM with a Buy rating. The target price for Summit Materials is set to $28. Summit Materials' shares closed at $24.22 yesterday.
FBR Capital initiated coverage on
Genocea Biosciences Inc with a Outperform rating. The target price for Genocea Biosciences is set to $20. Genocea Biosciences' shares closed at $12.93 yesterday.
Analysts at FBR Capital initiated coverage on
Zafgen IncZFGNLoading...
Loading...
with a Outperform rating. The target price for Zafgen is set to $60. Zafgen's shares closed at $36.58 yesterday.
Raymond James initiated coverage on
Community Bank System, Inc.CBU with a Market Perform rating. Community Bank System's shares closed at $35.64 yesterday.
Analysts at FBR Capital initiated coverage on
Biocryst Pharmaceuticals, Inc.BCRX with a Outperform rating. The target price for Biocryst Pharmaceuticals is set to $18. Biocryst Pharmaceuticals' shares closed at $10.29 yesterday.
FBR Capital initiated coverage on
Corcept Therapeutics IncorporatedCORT with a Outperform rating. The target price for Corcept Therapeutics is set to $12. Corcept Therapeutics' shares closed at $5.98 yesterday.
Loading...
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in